John Hart to Muromonab-CD3
This is a "connection" page, showing publications John Hart has written about Muromonab-CD3.
Connection Strength
0.018
-
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996 Aug 15; 62(3):370-5.
Score: 0.009
-
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
Score: 0.009